Clinical Trial Update: Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies

View source ↗

Summary

This document reports the completion of a clinical trial evaluating Kesimpta (ofatumumab) in relapsing multiple sclerosis patients transitioning from other ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Kesimpta (ofatumumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis | Status: COMPLETED